Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study.

MLA

Fendler, Annika, et al. “Adaptive Immunity and Neutralizing Antibodies against SARS-CoV-2 Variants of Concern Following Vaccination in Patients with Cancer: The CAPTURE Study.” Nature Cancer, vol. 2, no. 12, Dec. 2021, pp. 1305–20. EBSCOhost, https://doi.org/10.1038/s43018-021-00274-w.

APA

Fendler, A., Shepherd, S. T. C., Au, L., Wilkinson, K. A., Wu, M., Byrne, F., Cerrone, M., Schmitt, A. M., Joharatnam-Hogan, N., Shum, B., Tippu, Z., Rzeniewicz, K., Boos, L. A., Harvey, R., Carlyle, E., Edmonds, K., Del Rosario, L., Sarker, S., Lingard, K., … Turajlic, S. (2021). Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study. Nature Cancer, 2(12), 1305–1320. https://doi.org/10.1038/s43018-021-00274-w

Chicago

Fendler, Annika, Scott T C Shepherd, Lewis Au, Katalin A Wilkinson, Mary Wu, Fiona Byrne, Maddalena Cerrone, et al. 2021. “Adaptive Immunity and Neutralizing Antibodies against SARS-CoV-2 Variants of Concern Following Vaccination in Patients with Cancer: The CAPTURE Study.” Nature Cancer 2 (12): 1305–20. doi:10.1038/s43018-021-00274-w.